Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Creating diverse pool of trained scientists to address Alzheimer’s research needs

Creating diverse pool of trained scientists to address Alzheimer’s research needs

Roberta Diaz Brinton, PhD, an internationally recognized expert on Alzheimer’s disease and inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, has received a five-year, $1.8 million grant from the National Institutes of Health Institute on Aging.

With the funding, Dr. Brinton will develop a unique training program to cultivate a diverse pool of highly trained scientists from diverse fields who can effectively address the nation’s Alzheimer’s research needs.

“Curing Alzheimer’s disease requires a multidisciplinary approach. We have the team and the strategy to build an innovative, expertise-diverse team to address this challenge,” Dr. Brinton said. “Through this NIA training grant, we have the opportunity to innovate our national scientific and clinical workforce to develop therapeutics to address the epidemic of Alzheimer’s disease.”

To achieve that goal, Dr. Brinton and colleagues have designed an innovative, collaborative training program that is patient-inspired and data driven: the University of Arizona Translational Research on Alzheimer’s Disease and AD Related Dementias program, or AZ-TRADD.

“Our goal,” Dr. Brinton noted, “is to train the next generation of Alzheimer’s researchers in 21st century team science that spans translational, clinical and big data science. Our stellar team of University of Arizona translational faculty and community partners is uniquely qualified to support and foster AZ-TRADD. Importantly, the UA’s diverse, passionate and exceptional graduate and medical students are poised to be at the vanguard of innovators in developing cures for Alzheimer’s.”

“The innovative translational research at the University of Arizona into extending the cognitive health span to match our life spans is a strategic priority for the university and we are all thrilled by the incredible work that Dr. Brinton and her team are doing to understand Alzheimer’ disease,” said UA President Robert C. Robbins, MD. “I am confident that Dr. Brinton’s team of world-class translational Alzheimer’s researchers will develop the next generation of leaders in the field and, in turn, develop treatments and someday possible cures for this devastating disease that affects so many people across the globe.”

Based at the UAHS Center for Innovation in Brain Science and the UAHS Clinical Translational Sciences Program, led by Jorge Gomez, MD, PhD, the AZ-TRADD training program will recruit predoctoral PhD, MD and PhD/MD students from across multiple disciplines to serve as fellows.

“Our program is designed to develop innovative translational researchers who embrace the complexity of Alzheimer’s by providing them the best mentors and tools to cure this devastating disease,” Dr. Brinton said.

To achieve the program’s goal, Dr. Brinton has an “all brains on deck” approach. She is joined in this endeavor by UAHS Center for Innovation for Brain Science colleagues: Kathy Rodgers, PhD; Lalitha Madhaven, MD, PhD; Fei Yin, PhD; May Khanna, PhD; Kevin Gaffney, PhD; Rui Chang, PhD; Alex Thome, PhD; and 16 core faculty mentors across the University of Arizona, including UA McKnight Brain Institute members Carol Barnes, PhD, director and Regents’ Professor, Lee Ryan, PhD, and Meredith Hay, PhD; Anita Koshy, MD; and UA Data Science Institute Director Nirav Merchant.

Through a diverse team of UA faculty “accelerators,” AZ-TRADD fellows will receive in-depth training from UA experts in topics ranging from immunology to machine learning and therapeutic development. In addition, the program’s community partners — the Alzheimer’s Association Desert Southwest Chapter and the Critical Path Institute — will be key contributors.

In its inaugural year, the AZ-TRADD program will recruit six fellows.

The UA is one of three institutions in the United States and the first in the West to receive an NIA grant to develop training programs to advance translational research training for Alzheimer’s disease and related dementias.

Source:

https://opa.uahs.arizona.edu/newsroom/news/2019/every-front-developing-diverse-scientific-workforce-end-alzheimers-epidemic

Tagged with:

About author

Related Articles